Iain B. McInnes - 02 Sep 2021 Form 4 Insider Report for Evelo Biosciences, Inc.

Role
Director
Signature
/s/ Daniel S. Char, Attorney-in-Fact for Iain B. McInnes
Issuer symbol
EVLO on OTC
Transactions as of
02 Sep 2021
Net transactions value
$0
Form type
4
Filing time
07 Sep 2021, 06:59:31 UTC
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +35,000 $0.000000 35,000 02 Sep 2021 Common Stock 35,000 $11.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 36 substantially equal monthly installments following the grant date and has a term of 10 years.